Company profile
Idogen company profile
Idogen is a Swedish biotechnology company based in Lund. The Idogen share has been listed on Spotlight Stock Market since the 12th of June 2015 under the ticker IDOGEN and is traded through banks and stockbrokers. Idogen develops tolerogenic cell therapies to prevent the patient’s immune system from attacking biological agents, transplanted organs or the body’s own cells or tissues. The term “tolerogenic” refers to the immune system’s selective tolerance of a specific pathogenic or immune activating antigen following treatment with Idogen’s therapy. Idogen’s intention is to revolutionise the treatment of several disorders in which the body’s immune system does..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- https://idogen.com/en/
- Contact email
- [email protected]
- Phone number
- 046 – 275 63 30
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $0+
- Founded
- 2008-01-01
Headquarters
- Headquarters
- Lund, Skane Lan, Sweden
- Postal code
- 223 81
- Country code
- SE
- Continent
- Europe